12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Tuesday's intraday session, several healthcare stocks experienced significant movements. NexImmune (NEXI) saw a dramatic increase of 97.5%, while Cutera (CUTR) and Adicet Bio (ACET) also posted substantial gains. On the downside, Grifols (GRFS) and Genprex (GNPX) were among the biggest losers, with declines of 23.7% and 13.6%, respectively.
January 09, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Adicet Bio's stock increased by 32.72% to $3.27, with a market cap of $140.9 million.
The strong performance of Adicet Bio's stock could lead to further short-term gains as investors may continue to show interest.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Cutera stock climbed 36.47% to $4.49, with a market cap of $89.8 million.
Cutera's significant stock price increase may lead to continued investor interest in the short term, possibly driving the price further up.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
NexImmune shares soared 97.5% to $14.95, with a market cap of $15.8 million.
The substantial increase in NexImmune's stock price could attract more investor attention in the short term, potentially maintaining the upward momentum.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Genprex shares decreased by 13.6% to $0.24, with a market cap of $14.3 million.
The drop in Genprex's stock price may cause concern among investors, potentially leading to further short-term selling pressure.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Grifols shares fell sharply by 23.7% to $8.49, with a market cap of $5.7 billion.
Grifols' significant drop in stock price could lead to negative sentiment in the short term, potentially causing further declines.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100